{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:52:51Z","timestamp":1778010771749,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anndiagpath.2021.151736","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T04:00:05Z","timestamp":1616472005000},"page":"151736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["S100P as a marker for poor survival and advanced stage in gallbladder carcinoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Alka Mary","family":"Mathai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Ming","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kar-Ming","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William P.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camtu","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151736_bb0005","doi-asserted-by":"crossref","unstructured":"Van Dyke AL, Shiels MS, Jones GS, Pfeiffer RM, Petrick JL, Beebe-Dimmer JL et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013. Cancer. 2019;125:1489\u201398. doi:https:\/\/doi.org\/10.1002\/cncr.31942.","DOI":"10.1002\/cncr.31942"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0010","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","article-title":"Cholangiocarcinoma: modern advances in understanding a deadly old disease","volume":"45","author":"Malhi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0020","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.gassur.2005.12.002","article-title":"Predictors of long-term survival in patients with gallbladder cancer","volume":"10","author":"Balachandran","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0025","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma","volume":"14","author":"Kim","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12253-013-9710-5","article-title":"Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0040","article-title":"miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.10222","article-title":"Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder","volume":"98","author":"Kawamoto","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0050","doi-asserted-by":"crossref","unstructured":"Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y, Kuroda Y (2002) Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20:937\u2013941.","DOI":"10.3892\/ijo.20.5.937"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humpath.2003.10.012","article-title":"Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays","volume":"35","author":"Swierczynski","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0060","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s12032-011-0110-y","article-title":"NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma","volume":"29","author":"Song","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152925","article-title":"Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma","volume":"216","author":"Hedegaard Jensen","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0070","doi-asserted-by":"crossref","unstructured":"Aksoy-Altinboga A, Baglan T, Umudum H, Ceyhan K. Diagnostic value of S100p, IMP3, Maspin, and pVHL in the differantial diagnosis of pancreatic ductal adenocarcinoma and normal\/chronic pancreatitis in fine needle aspiration biopsy. J Cytol. 2018;35:247\u2013251. doi:https:\/\/doi.org\/10.4103\/JOC.JOC_18_17.","DOI":"10.4103\/JOC.JOC_18_17"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cancergen.2016.02.002","article-title":"Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma","volume":"209","author":"Shen","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0080","doi-asserted-by":"crossref","unstructured":"Kikuchi K, McNamara KM, Miki Y, Iwabuchi E, Kanai A, Miyashita M et al. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells. Cell Oncol (Dordr). 2019;42:67\u201380. doi:https:\/\/doi.org\/10.1007\/s13402-018-0408-2.","DOI":"10.1007\/s13402-018-0408-2"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/acs.jproteome.5b00819","article-title":"Quantitative secretomic analysis identifies extracellular protein factors that modulate the metastatic phenotype of non-small cell lung cancer","volume":"15","author":"Hu","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6890-8-2","article-title":"The calcium-binding protein S100P in normal and malignant human tissues","volume":"8","author":"Parkkila","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0095","unstructured":"Prica F, Radon T, Cheng Y, Crnogorac-Jurcevic T (2006) The life and works of S100P - from conception to cancer. Am J Cancer Res 6:562\u2013576."},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/PAS.0b013e31815701d1","article-title":"Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis","volume":"32","author":"Lin","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0110","series-title":"vol","article-title":"WHO classification of tumors of the digestive tract","volume":"vol. 1","author":"WHO Classification of Tumours Editorial Board","year":"2019"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4143\/crt.2019.271","article-title":"Validation of the 8th edition of the American joint committee on cancer staging system for gallbladder cancer and implications for the follow-up of patients without node dissection","volume":"52","author":"Sung","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0120","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.21037\/jgo.2018.08.10","article-title":"External validation of the 8th American Joint Committee on CANCER staging system for gall bladder carcinoma","volume":"9","author":"Oweira","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.humpath.2012.06.010","article-title":"Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder","volume":"44","author":"Shi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0130","doi-asserted-by":"crossref","unstructured":"Li Z, Chen Y, Wang X, Zhang H, Zhang Y, Gao Y et al. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2\/M phase in gallbladder cancer by down-regulating S100P via the PI3K\/AKT pathway. Cancer Lett. 2016;372:239\u201350. doi:https:\/\/doi.org\/10.1016\/j.canlet.2016.01.008.","DOI":"10.1016\/j.canlet.2016.01.008"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1349-7006.2010.01757.x","article-title":"Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma","volume":"102","author":"Hamada","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.29721","article-title":"Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma","volume":"138","author":"Wu","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0145","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1365-2559.2012.04316.x","article-title":"S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas","volume":"61","author":"Tsai","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0150","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PAI.0b013e318245e05b","article-title":"Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy","volume":"20","author":"Schmidt","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0155","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.humpath.2010.01.014","article-title":"S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy","volume":"41","author":"Levy","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00534-012-0581-z","article-title":"Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma","volume":"20","author":"Kawashima","year":"2013","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.humpath.2013.10.004","article-title":"Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma","volume":"45","author":"Lok","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-011-1062-5","article-title":"Calcium-binding protein S100P and cancer: mechanisms and clinical relevance","volume":"138","author":"Jiang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00726-010-0495-5","article-title":"Transcriptional regulation and functional implication of S100P in cancer","volume":"41","author":"Gibadulinova","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0180","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/cancers12082037","article-title":"Friend or foe: S100 proteins in cancer","volume":"12","author":"Allg\u00f6wer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4149\/av_2013_02_238","article-title":"S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer","volume":"57","author":"T\u00f3thov\u00e1","year":"2013","journal-title":"Acta Virol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112621","article-title":"Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells","volume":"203","author":"Camara","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0195","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1535-7163.MCT-12-0771","article-title":"Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy","volume":"12","author":"Arumugam","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0200","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-12-0221","article-title":"S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis","volume":"18","author":"Arumugam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0205","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1042\/BCJ20170578","article-title":"Activation of tissue plasminogen activator by metastasis-inducing S100P protein","volume":"474","author":"Clarke","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0210","doi-asserted-by":"crossref","first-page":"22508","DOI":"10.18632\/oncotarget.7999","article-title":"Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance","volume":"7","author":"Gibadulinova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)62234-1","article-title":"Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer","volume":"166","author":"Dowen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151736_bb0220","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.onc.1207269","article-title":"Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling","volume":"23","author":"Sato","year":"2004","journal-title":"Oncogene"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:29Z","timestamp":1761078809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"alternative-id":["S1092913421000368"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151736","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S100P as a marker for poor survival and advanced stage in gallbladder carcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151736"}}